Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy — VSSIIH  

Idiopathic Intracranial Hypertension (IIH) Clinical Trial

Official title: Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy

Status Completed

Clinical Trial Summary

Idiopathic Intracranial Hypertension (IIH) is a disease that affects mainly young people, and is associated with headache and loss of vision. The medical and surgical management of IIH is problematic and many patients are not treated effectively. Some cases of IIH are associated with severe stenosis of the large veins of the brain and various researchers have recently reported significant improvement in patients with IIH after the narrow veins of the brain were treated with a stent. Our project aims to evaluate the safety and long-term efficacy of venous sinus stenting in patients with severe IIH refractory to medical management.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Hypertension
• Idiopathic Intracranial Hypertension (IIH)
• Intracranial Hypertension
• Pseudotumor Cerebri

• NCT number: NCT01407809
• Study type: Interventional
• Source: Weill Medical College of Cornell University
• Status: Completed
• Phase: Phase 1
• Start date: January 2012
• Completion date: June 1, 2020